Anacor Pharmaceuticals Announces Award of $100M in Arbitration with Valeant

Loading...
Loading...
Anacor Pharmaceuticals
ANAC
today announced that the arbitrator appointed to resolve its dispute with Valeant Pharmaceuticals, Inc.
VRX
, successor in interest to Dow Pharmaceutical Sciences, Inc. (DPS), has issued an Interim Final Award in favor of Anacor, awarding Anacor $100 million in damages as well as all costs of the arbitration and reasonable attorney's fees. The parties may apprise the arbitrator of any issues not resolved in the Interim Final Award order within ten days, and responses to any such submission are due within fifteen days of the date of the Interim Final Award. If no submissions are made, this Interim Final Award will become final The
See full press release
Posted In: EarningsNewsGuidanceContractsBuybacksLegalManagementGlobal
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...